SPEC PerkinElmer 10.13
News|Articles|April 29, 2025

Non-Invasive Endometriosis Diagnosis Using Infrared Spectroscopy

Author(s)Will Wetzel
Fact checked by: Jerome Workman, Jr.

A recent study conducted by scientists in Brazil saw the development of a quick, non-invasive method to diagnose endometriosis.

In a recent study conducted by researchers from Brazil’s Federal University of Rio Grande do Norte, an important women’s health issue was investigated. The study, which was led by Kassio Michell Gomes de Lima, a researcher at the Federal University of Rio Grande do Norte, explored how endometriosis detection can be improved using spectroscopy. This study presents a new, fast, cost-effective, and non-invasive diagnostic method based on blood plasma analysis (1). The insights presented in this study, which was published in Scientific Reports, show how infrared (IR) spectroscopy can improve the early detection of endometriosis in women.

Endometriosis is a medical issue that affects the lining of the uterus in women. Instead of growing normally, the lining of the uterus grows outside the uterus, and this can cause the woman to feel severe pain in the pelvis and have difficulties getting pregnant (2). Women affected with endometriosis can also experience symptoms such as severe pain when urinating, nausea, abdominal bloating and pain, and sometimes depression and anxiety (2). This disease impacts approximately 10% of reproductive-age women worldwide, and there is currently no known cure (2).

As a result, researchers are primarily focused on early diagnosis and effective treatments. The problem is that current diagnostic methods, including laparoscopy, are invasive, expensive, and not always readily accessible (1). Therefore, researchers are looking for alternative strategies that could offer quicker diagnoses.

In this study, the researchers applied a combination of attenuated total reflection Fourier-transform infrared (ATR FT-IR) and near-infrared (NIR) spectroscopy techniques to blood plasma samples from two groups: women diagnosed with endometriosis (n = 41) and healthy individuals (n = 34). NIR and ATR FT-IR are not effective techniques on their own, but when they were integrated with multivariate classification models, the researchers found that they could differentiate between affected and unaffected patients (1).

The multivariate analysis methods used in this study include principal component analysis–linear discriminant analysis (PCA-LDA), successive projections algorithm–linear discriminant analysis (SPA-LDA), and genetic algorithm–linear discriminant analysis (GA-LDA). These models demonstrated impressive discriminant power, achieving improved levels of sensitivity, specificity, and overall accuracy (1). The fusion of ATR FT-IR and NIR data allowed for a more nuanced classification, which improved the reliability of the results (1).

One of the study’s most important findings was the strong positive correlations observed between spectrochemical biomarkers in both infrared (IR) regions through two-dimensional (2D) correlation analysis. This biochemical "cell fingerprint," as the researchers described in their study, captured the unique chemical alterations in blood plasma caused by endometriosis, providing a powerful diagnostic signature (1).

There are potentially important implications for clinical analysis in this study. By enabling early-stage detection through a simple blood test, healthcare providers could significantly reduce the time to diagnosis and initiate treatment sooner (1). Furthermore, the non-destructive nature of IR spectroscopy means that sample integrity is preserved, facilitating repeated analysis if needed without additional patient discomfort.

In medical diagnostics, IR spectroscopy is being routinely used with chemometrics because this integration allows for the swift detection of complex biochemical changes in biological samples (1). Based on the success of this technique for other disease detection applications, using IR spectroscopy with chemometrics for this purpose makes it an appealing tool to detect endometriosis, which currently lacks simple screening methods (1).

Ultimately, the researchers hope that future studies validate their findings by conducting larger clinical trials across diverse populations (1). Doing so, they state in their study, would help improve their approach (1). The research team at the Federal University of Rio Grande do Norte is optimistic that, with further development, this methodology could be integrated into routine gynecological exams within the next decade.

References

  1. Barros de Souza, A. T.; Figueira Camara, A. B.; de Araujo Medeiros Santos, C. M.; et al. Spectrochemical Differentiation in Endometriosis based on Infrared Spectroscopy, Advanced Data Fusion and Multivariate Analysis. Sci. Rep. 2025, 15, 5071. DOI: 10.1038/s41598-025-89504-0
  2. World Health Organization, Endometriosis. WHO.int. Available at: https://www.who.int/news-room/fact-sheets/detail/endometriosis#:~:text=Endometriosis%20is%20a%20disease%20in,period%20and%20last%20until%20menopause. (accessed 2025-04-28).

Related to this article

Sparks near Reno Nevada – Site of 2026 SciX Conference ©   DTM Media  -chronicles-stock.adobe.com
Wednesday's program at SciX 2026 kept returning to one question: can spectroscopy perform outside the controlled laboratory? Speakers took surface-enhanced Raman scattering (SERS), laser-induced breakdown spectroscopy (LIBS), mid-infrared photonics, chemometrics, and fluorescence excitation–emission matrix (EEM) spectroscopy into clinics, food plants, reactor coolant loops, brine fields, and drinking water supplies.
Nancy Pleshko (left) is a Laura H. Carnell Professor Emerita in Temple University's Department of Bioengineering. Petra A. Baylin (right) is a research assistant in the Tissue Imaging and Spectroscopy Lab at Temple University. Photo Credits: © Nancy Pleshko and Petra Baylin
As part of our coverage of the SciX 2026 Conference, Nancy Pleshko and Petra Baylin of Temple University sat down with Spectroscopy to talk about their recent study, explaining how Fourier transform infrared (FT-IR) imaging of ultra-high weight molecular polyethylene (UHMWPE) implants permits oxidation evaluation throughout the sample yielding insight into failure.
Infrared Reimagined: How FT-IR Spectroscopy Learned to Read Molecules, ©  Luis Eduardo  -chronicles-stock.adobe.com
FT-IR spectroscopy, long treated as a mature bench technique for confirming a carbonyl stretch or fingerprinting a polymer, has quietly become one of chemistry’s most versatile discovery engines: it now infers molecular structure straight from a spectrum without a reference library, resolves chemistry tens of nanometers wide, and screens a fingerstick of blood for disease in minutes. The last five years of published research show FT-IR moving from a confirmatory tool into a predictive, autonomous, and field-ready analytical platform.
NIR Spectroscopy of the Brain and Other Complex Analyses, ©   Navaporn  -chronicles-stock.adobe.com
Near-infrared spectroscopy has quietly stopped being a niche calibration exercise and started acting like an autonomous diagnostic partner, reading consciousness in an injured brain, steering a fermenter without a human hand, and hunting invisible plastic in a glass of water. The tool chemists once used to check moisture in grain is now fusing with artificial intelligence to make decisions no spectrometer could make alone.
FACSS 2026 Award Interviews ©  Erin -chronicles-stock.adobe.com
Eight FACSS award winners at SciX 2026, One LIBS trailblazer. Forty-eight questions. And not one of them is a softball. Award season in spectroscopy usually means polite applause, a plaque, and a photo. We're not completely interested only in the award sessions. The eight scientists honored at SciX 2026 in Sparks, Nevada, along with LIBS researcher Alessandro De Giacomo, are pushing Raman into operating rooms, flying LIBS on drones, reading chemistry off Mars, and tracing toxic metals downwind of industrial sites. Their work makes big claims. In the coming days, Spectroscopy will sit down with eight of these researchers and ask whether those claims hold up. The interviews that follow won't just celebrate. They'll press on the gaps between simulation and experiment, between the lab bench and the clinic, and between a clever paper and an instrument someone will actually buy and use.